| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.76B | 13.32B | 9.28B | 9.74B | 10.43B | 8.05B |
| Gross Profit | 9.76B | 12.24B | 8.95B | 9.72B | 10.40B | 8.01B |
| EBITDA | 403.00M | 2.14B | 1.79B | 1.26B | 2.01B | 809.00M |
| Net Income | 1.03B | 1.05B | 954.00M | 632.00M | 972.00M | 333.00M |
Balance Sheet | ||||||
| Total Assets | 561.17B | 560.66B | 548.42B | 552.20B | 551.29B | 569.87B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 31.81B | 30.67B | 33.31B | 30.16B | 36.79B |
| Total Debt | 14.77B | 10.77B | 11.56B | 18.27B | 18.73B | 35.23B |
| Total Liabilities | 531.16B | 528.69B | 519.07B | 520.89B | 521.04B | 537.55B |
| Stockholders Equity | 29.11B | 31.03B | 28.45B | 30.43B | 29.40B | 31.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -479.00M | 0.00 | -2.16B | -19.88B | 11.13B |
| Operating Cash Flow | 0.00 | -170.00M | 0.00 | 2.64B | -19.22B | 11.28B |
| Investing Cash Flow | 0.00 | -9.81B | 1.87B | 972.00M | 13.79B | -13.30B |
| Financing Cash Flow | 0.00 | 9.53B | 2.92B | -272.00M | -272.00M | -341.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥14.33B | 9.59 | ― | 3.30% | 20.18% | 20.57% | |
68 Neutral | ¥12.93B | 7.27 | ― | 3.74% | 15.32% | 26.30% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | ¥13.75B | 22.30 | ― | 3.58% | 18.86% | 59.05% | |
60 Neutral | ¥13.07B | 17.45 | ― | 2.74% | 17.43% | -35.15% | |
58 Neutral | ¥11.40B | 9.94 | ― | 2.68% | 24.95% | 10.64% | |
52 Neutral | ¥12.94B | 10.90 | ― | 1.89% | 17.42% | ― |